<DOC>
	<DOC>NCT00479882</DOC>
	<brief_summary>This is a 20-week clinical trial in participants with primary hypercholesterolemia or mixed dyslipidemia to demonstrate the effect of MK-0524B compared to MK-0524A + Simvastatin on lipid values.</brief_summary>
	<brief_title>MK-0524B Lipid Study (MK-0524B-063)</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Dyslipidemias</mesh_term>
	<mesh_term>Simvastatin</mesh_term>
	<criteria>has primary hypercholesterolemia or mixed dyslipidemia based on medical history (previous diagnosis), historic lipid values, or as otherwise determined through optional lipid measurements at screening visit meets one of the following triglyceride (TG) criteria: 1. is on niacin, statin, or fibrate and has TG &lt;500 mg/dL at or within 6 months of washout 2. is not on any lipid altering therapy or is on lipid altering therapy other than niacin, statin, or fibrate and has TG &lt;600 mg/dL at or within 6 months of screening is high risk (coronary heart disease [CHD] or CHD risk equivalent) AND is on a statin is pregnant or breastfeeding, or expecting to conceive during the study including the 14day post study followup has Type 1 or Type 2 diabetes mellitus and is on statin therapy, is poorly controlled, is newly diagnosed (within 3 months of Visit 1), has recently experienced repeated hypoglycemia or unstable glycemic control or is taking new or recently adjusted antidiabetic medications (with the exception of +/ 10 units of insulin) within 3 months of Visit 1 has the following conditions: chronic heart failure, uncontrolled/unstable cardiac arrhythmias, unstable hypertension, active or chronic hepatobiliary disorder or hepatic disease, human immunodeficiency virus (HIV) positive, gout (within 1 year)</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>